The National Pharmaceutical Council takes issue with ICER’s collaboration with the VA’s PBM. Find out what both camps are saying.
CVS Health’s Troyen A. Brennan, MD, MPH, brings attention to a unique specialty pharmacy model and value-based contracting.
Pre-drug-approval forecasting and budgeting is increasingly important for payers. Is a safe harbor for manufacturers necessary?
Across the country more states are taking steps to limit patients’ exposure to surprise out-of-network bills.
AHIP’s president and CEO Marilyn Tavenner discusses the association’s top priorities, challenges, and opportunities.
What impact will MACRA have on your organization? We asked experts to tell us.
The first-year results of the ACA’s Risk Adjustment Program are in. Find out how it worked out and what insurers need to do next.
The transition to value-based payment has accelerated rapidly over the past two years, and payers and providers predict even more dramatic changes.